Optimum is hiring!
Do you want to help advise some of the world’s leading healthcare and life sciences companies that are developing novel medicines and treatments to improve the quality of life for millions of people?
How Early-stage VCs are Adjusting in a Bear Market
As part of a panel session, hosted by Stephen Hansen, at the Anglonordic Life Science conference on 5 May, Optimum’s clients explored the latest dynamics of syndicate building for early-stage VCs.
Chief Business Officers: Shedding Light on Biotech’s Dealmakers
Stephanie Bewick, Chief Business Officer at Destiny Pharma outlines her experiences of how a CBO maximises their company’s commercial appeal and lands deals in the biotech industry…
In Vivo’s 30 ‘Rising Leaders’ Announced
The 3rd annual listing of In Vivo’s ‘Rising Leaders’ has landed! Optimum is thrilled to see our brilliant clients from M Ventures, INKEF Capital, BioQube, Healthcap and Octarine recognised alongside other leading entrepreneurs and innovators in healthcare, from all across the globe. The 30 people spotlighted have been recognized for bringing something new to the […]
LSX World Congress 2022
Optimum is a proud supporter of LSX. Every year it’s World Congress gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between.
